No price history available.
Key financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | HKDm | 5,761 | 6,107 | 5,119 | 4,838 | 4,829 | N/A | 4,818 | N/A |
| Operating profit | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | HKDm | 358 | 257 | 85 | 201 | 303 | N/A | 291 | N/A |
| EPS reported | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
As an investment holding company, Lam Soon (Hong Kong) Limited is involved in the manufacturing, trading, and processing of edible oils, flour-based goods, and home care products across Hong Kong, mainland China, and Macau. The firm operates through two primary divisions: Food and Home Care. Its Food segment is responsible for producing and distributing a variety of food items, including flour, cooking oils, and specialized fats, serving both the catering industry and general consumers, alongside trading and distributing health products. The Home Care segment, conversely, focuses on manufacturing and supplying household and institutional cleaning solutions, such as liquid dish soaps, laundry powders and liquids, fabric softeners, floor cleaners, and industrial marble cleaners. Lam Soon (Hong Kong) Limited markets its diverse product portfolio under well-known brands like Golden Statue, American Roses, Royal Sakura, Golden Double Peach, Knife, Red Lantern, Soon, AXE, Labour, and Procleanic. Beyond these core activities, the company also engages in the distribution of agency products and offers a range of services including truck rental, warehousing, logistics, IT support, silo facilities, and trustee services. Furthermore, it holds interests in property and trademarks, and licenses factory canteens. Founded in 1961, the company maintains its headquarters in Tai Po, Hong Kong, and is a subsidiary of Guoline International Limited.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Lam Soon (Hong Kong) Limited (0411.HK)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
As an investment holding company, Lam Soon (Hong Kong) Limited is involved in the manufacturing, trading, and processing of edible oils, flour-based goods, and home care products across Hong Kong, mainland China, and Macau. The firm operates through two primary divisions: Food and Home Care. Its Food segment is responsible for producing and distributing a variety of food items, including flour, cooking oils, and specialized fats, serving both the catering industry and general consumers, alongside trading and distributing health products. The Home Care segment, conversely, focuses on manufacturing and supplying household and institutional cleaning solutions, such as liquid dish soaps, laundry powders and liquids, fabric softeners, floor cleaners, and industrial marble cleaners. Lam Soon (Hong Kong) Limited markets its diverse product portfolio under well-known brands like Golden Statue, American Roses, Royal Sakura, Golden Double Peach, Knife, Red Lantern, Soon, AXE, Labour, and Procleanic. Beyond these core activities, the company also engages in the distribution of agency products and offers a range of services including truck rental, warehousing, logistics, IT support, silo facilities, and trustee services. Furthermore, it holds interests in property and trademarks, and licenses factory canteens. Founded in 1961, the company maintains its headquarters in Tai Po, Hong Kong, and is a subsidiary of Guoline International Limited.
